Compare Twist Bioscience Corp (TWST) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs United Parcel Service Inc — how do they compare? Twist Bioscience Corp trades at $125.52 (market cap $8.42B), while United Parcel Service Inc trades at $99.69 (market cap $85.49B). The key difference: United Parcel Service Inc is far larger — about 10.2× Twist Bioscience Corp's market cap, and United Parcel Service Inc pays a 6.53% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | UPS | |
|---|---|---|
Market Cap | $8.42B | $85.49B |
Sector | Health | Industrials |
52-Week High | $153.10 | $120.00 |
52-Week Low | $24.16 | $82.58 |
Enterprise Value | $8.35B | $109.51B |
Volume | — | 2,288,643 |
Dividend Yield | — | 6.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Twist Bioscience (TWST) trades at $128.06, up 2.68% today, but remains below the analyst consensus price target of $106.14. The stock shows mixed technical signals with bearish overall momentum but bullish moving averages. Fundamentally, the company continues to report losses with a net income margin of -31.66% despite 23% revenue growth in Q3 2026. Recent news highlights AI-driven optimism and institutional buying interest.
TWST presents a high-risk growth story with strong analyst support (79% buy ratings) but persistent profitability challenges. The stock's valuation appears stretched with P/S of 18.09 and P/B of 18.89. Key catalysts include AI drug discovery partnerships and path to EBITDA breakeven, while risks include cash burn and competitive pressures in biotech.
UPS stock trades at $100.48, down 1.78% on the day, with a bearish technical signal from moving averages but neutral oscillators. Recent earnings beats in Q4 2025, Q1 2026, and Q2 2026 highlight operational strength, though revenue has declined from $100.3B in 2022 to $88.7B in 2025. The company announced a $2B+ global investment to enhance logistics and appointed a new Chief Global Operations Officer, signaling strategic shifts. Valuation metrics include a P/E of 18.68 and P/S of 0.95, with a dividend yield of 6.2% based on the $1.64 per share payout.
The outlook is mixed: analyst consensus leans neutral with a $117.90 price target, but risks include declining net income margins and high dividend payout ratios limiting investment flexibility. Upside potential exists from efficiency gains and global expansion, while macroeconomic pressures and competitive threats pose challenges for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
